Small Molecule Drug Discovery
Automation and Miniaturization Leads
to Robust Screening Campaigns
Miniaturization is key to facilitating higher throughput, increasing reliability and accuracy and reducing costs for screening large compound libraries. We have a solid track record in miniaturizing challenging assays to 384- and 1536-well formats for medium to Ultra-High-Throughput Screening (uHTS).
Unprecedented Remote Access to a
Smart Drug Discovery Laboratory
Strateos’ smart labs collectively span over 14K sqft and are composed of automated workcells that integrate hundred of instruments which include a wide range of robust liquid handling instruments, accurate dispensers, plate washers and more to support miniaturization and automation of challenging biochemical and cellular assays.
Learn More About the Automated Drug Discovery Modules
The smart lab physically and virtually integrates several areas of the drug discovery process together creating a state-of-the-art, automated drug discovery platform. The custom engineered Magnemotion track based layout, and scheduling and execution software integrates the automation modules, contextualizing data in an end-to-end laboratory workflow.